Papers
1
Total Citations
137
H-Index
1
About
Xiaojing Bai is a leading researcher in urologic oncology, with a primary focus on advancing surgical outcomes for prostate cancer patients. Her most impactful work centers on the comparative effectiveness of robotic-assisted surgery, as demonstrated by her highly cited 2018 systematic review and meta-analysis on robot-assisted radical prostatectomy (RARP). This seminal study, with 137 citations, rigorously evaluated perioperative, functional, and oncologic outcomes across RARP, laparoscopic, and open surgical approaches, providing critical evidence that RARP offers superior benefits for patients. By synthesizing inconsistent data from global studies, Bai’s work has helped guide clinical decision-making and solidified robotic surgery as a preferred technique. Her contributions are particularly valuable for surgeons and researchers seeking to optimize cancer care while minimizing recovery times and complications. Bai’s research exemplifies the integration of evidence-based medicine with cutting-edge technology, making her a key voice in the ongoing evolution of minimally invasive urologic surgery. Her meta-analysis remains a cornerstone reference for those studying prostate cancer treatment pathways.
Research Focus
Key Achievements
Top Papers
- 1